DOP2006000150A - NON-STEROID MODULAR PROGESTERONE RECEPTORS - Google Patents
NON-STEROID MODULAR PROGESTERONE RECEPTORSInfo
- Publication number
- DOP2006000150A DOP2006000150A DO2006000150A DO2006000150A DOP2006000150A DO P2006000150 A DOP2006000150 A DO P2006000150A DO 2006000150 A DO2006000150 A DO 2006000150A DO 2006000150 A DO2006000150 A DO 2006000150A DO P2006000150 A DOP2006000150 A DO P2006000150A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- steroid
- modular
- therapy
- progesterone receptors
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
Abstract
La presente invencion se refiere a moduladores no esteroides del receptor de progesterona de la formula general I, a su use para la preparacion de medicamentos, asi como a las composiciones farmaceuticas que contienen estos compuestos. Los compuestos segun la invencion son apropiados para la terapia y la prevencion de enfermedades ginecologicas tales como endometriosis, leiomiomas de utero, hemorragias disfuncionales y dismenorrea y para la terapia y la prevencion de tumores dependientes de hormonas y para el use para el control de la fertilidad femenina y para la terapia de reemplazo hormonal.The present invention relates to non-steroidal modulators of the progesterone receptor of the general formula I, to its use for the preparation of medicaments, as well as to the pharmaceutical compositions containing these compounds. The compounds according to the invention are suitable for the therapy and prevention of gynecological diseases such as endometriosis, uterine leiomyomas, dysfunctional hemorrhages and dysmenorrhea and for the therapy and prevention of hormone-dependent tumors and for use in fertility control. female and for hormone replacement therapy.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005030294A DE102005030294A1 (en) | 2005-06-24 | 2005-06-24 | Nonsteroidal progesterone receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2006000150A true DOP2006000150A (en) | 2006-12-31 |
Family
ID=36716643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2006000150A DOP2006000150A (en) | 2005-06-24 | 2006-06-26 | NON-STEROID MODULAR PROGESTERONE RECEPTORS |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1899315A1 (en) |
JP (1) | JP2008543911A (en) |
KR (1) | KR20080018275A (en) |
CN (1) | CN101248056A (en) |
AR (1) | AR057409A1 (en) |
AU (1) | AU2006261049A1 (en) |
BR (1) | BRPI0612305A2 (en) |
CA (1) | CA2611900A1 (en) |
CR (1) | CR9595A (en) |
DE (1) | DE102005030294A1 (en) |
DO (1) | DOP2006000150A (en) |
EA (1) | EA200702604A1 (en) |
EC (1) | ECSP078043A (en) |
GT (1) | GT200600272A (en) |
IL (1) | IL188022A0 (en) |
MX (1) | MX2008000070A (en) |
NO (1) | NO20080441L (en) |
PE (1) | PE20070170A1 (en) |
TW (1) | TW200738665A (en) |
UY (1) | UY29626A1 (en) |
WO (1) | WO2006136462A1 (en) |
ZA (1) | ZA200800689B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY30805A1 (en) * | 2006-12-21 | 2008-07-31 | Bayer Schering Pharma Ag | NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS |
DE102007032800A1 (en) * | 2007-07-10 | 2009-01-15 | Bayer Schering Pharma Aktiengesellschaft | Nonsteroidal progesterone receptor modulators |
DE102007058747A1 (en) * | 2007-12-05 | 2009-06-10 | Bayer Schering Pharma Aktiengesellschaft | Nonsteroidal progesterone receptor modulators |
TWI477276B (en) * | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | Antiprogestin dosing regimens |
ES2701400T3 (en) | 2012-05-31 | 2019-02-22 | Repros Therapeutics Inc | Formulations for vaginal administration of antiprogestins |
JP6343619B2 (en) | 2012-11-02 | 2018-06-13 | レプロス セラピューティクス インコーポレイティド | Methods and compositions for treating progesterone-dependent conditions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19723722A1 (en) * | 1997-05-30 | 1998-12-10 | Schering Ag | Nonsteroidal progestogens |
WO2000066590A2 (en) * | 1999-05-04 | 2000-11-09 | Ligand Pharmaceuticals, Inc. | Tetracyclic progesterone receptor modulator compounds and methods |
US6358948B1 (en) * | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
CA2472746A1 (en) * | 2002-01-14 | 2003-07-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
ES2280766T3 (en) * | 2002-03-11 | 2007-09-16 | Bayer Schering Pharma Aktiengesellschaft | 5- (2-HIDROXI-3'-1- (3-TRIFLUOROMETILFENIL) -CICLOPROPIL) -PROPIONILAMINO) -FTALIDA AND RELATED COMPOUNDS WITH MODULATING ACTIVITY OF THE PROGESTERONE RECEIVER, FOR USE IN FERTILITY CONTROL AND REPLACEMENT THERAPY. |
DE10346939A1 (en) * | 2003-10-06 | 2005-05-19 | Schering Ag | New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |
-
2005
- 2005-06-24 DE DE102005030294A patent/DE102005030294A1/en not_active Ceased
-
2006
- 2006-06-22 AU AU2006261049A patent/AU2006261049A1/en not_active Abandoned
- 2006-06-22 CA CA002611900A patent/CA2611900A1/en not_active Abandoned
- 2006-06-22 KR KR1020087001789A patent/KR20080018275A/en not_active Application Discontinuation
- 2006-06-22 BR BRPI0612305-8A patent/BRPI0612305A2/en not_active Application Discontinuation
- 2006-06-22 WO PCT/EP2006/006532 patent/WO2006136462A1/en active Application Filing
- 2006-06-22 JP JP2008517445A patent/JP2008543911A/en active Pending
- 2006-06-22 EP EP06762405A patent/EP1899315A1/en not_active Withdrawn
- 2006-06-22 MX MX2008000070A patent/MX2008000070A/en not_active Application Discontinuation
- 2006-06-22 CN CNA2006800306699A patent/CN101248056A/en active Pending
- 2006-06-22 EA EA200702604A patent/EA200702604A1/en unknown
- 2006-06-23 TW TW095122741A patent/TW200738665A/en unknown
- 2006-06-26 UY UY29626A patent/UY29626A1/en not_active Application Discontinuation
- 2006-06-26 DO DO2006000150A patent/DOP2006000150A/en unknown
- 2006-06-26 PE PE2006000732A patent/PE20070170A1/en not_active Application Discontinuation
- 2006-06-26 GT GT200600272A patent/GT200600272A/en unknown
- 2006-06-27 AR ARP060102752A patent/AR057409A1/en unknown
-
2007
- 2007-12-10 IL IL188022A patent/IL188022A0/en unknown
- 2007-12-14 CR CR9595A patent/CR9595A/en not_active Application Discontinuation
- 2007-12-21 EC EC2007008043A patent/ECSP078043A/en unknown
-
2008
- 2008-01-23 NO NO20080441A patent/NO20080441L/en not_active Application Discontinuation
- 2008-01-23 ZA ZA200800689A patent/ZA200800689B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1899315A1 (en) | 2008-03-19 |
JP2008543911A (en) | 2008-12-04 |
NO20080441L (en) | 2008-03-07 |
DE102005030294A1 (en) | 2007-01-04 |
PE20070170A1 (en) | 2007-03-02 |
MX2008000070A (en) | 2008-03-19 |
CR9595A (en) | 2008-05-05 |
GT200600272A (en) | 2007-08-20 |
KR20080018275A (en) | 2008-02-27 |
CN101248056A (en) | 2008-08-20 |
IL188022A0 (en) | 2008-03-20 |
AR057409A1 (en) | 2007-12-05 |
BRPI0612305A2 (en) | 2010-11-03 |
ECSP078043A (en) | 2008-01-23 |
AU2006261049A1 (en) | 2006-12-28 |
WO2006136462A1 (en) | 2006-12-28 |
UY29626A1 (en) | 2007-01-31 |
TW200738665A (en) | 2007-10-16 |
CA2611900A1 (en) | 2006-12-28 |
EA200702604A1 (en) | 2008-06-30 |
ZA200800689B (en) | 2009-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY33470A (en) | DERIVATIVES OF 6,7-DIHIDRO-5H-BENZO [7] ANNULMENTS, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE FOR THE PREPARATION OF MEDICINES | |
ECSP18047708A (en) | 17-HYDROXY-17-PENTAFLUOROETHYL-ESTRA-4,9 (10) -DIEN-11-ARYL DERIVATIVES AS PROGESTERONE ANTAGONISTS AND PROCEDURES FOR THEIR PREPARATION | |
DOP2006000150A (en) | NON-STEROID MODULAR PROGESTERONE RECEPTORS | |
CR10875A (en) | DERIVATIVES OF ESTER AND AMIDA OF INDAZOLILO FOR THE TREATMENT OF DISEASES MEDIATED BY A GLUCOCORTICOID RECEPTOR | |
SV2010003580A (en) | NEW AGONISTS OF GLUCOCORTICOID RECEPTORS | |
AR054586A1 (en) | USE OF PROGESTERONE RECEIVER MODULATORS | |
CU20140064A7 (en) | DERIVATIVES OF 6,7- DIHIDRO-5H-BENZO [7] CANCELLATION, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL PRODUCTS THAT INCLUDE THE SAME AND ITS USE IN THE PREPARATION OF MEDICINES | |
BR0312054A (en) | Use of thiooxyindole derivatives in the preparation of medicaments useful in the treatment of hormone related conditions, and pharmaceutical kit | |
DOP2006000147A (en) | USE OF NON-STEROID MODULARS OF PROGESTERONE RECEPTORS. | |
PE20211588A1 (en) | COMPOUNDS AND THEIR USES TO RELIEVE SYMPTOMS ASSOCIATED WITH MENOPAUSE | |
DOP2006000148A (en) | NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS | |
CR11479A (en) | PIPERAZINAS AS ANTIOBESITY AGENTS | |
CR9627A (en) | CYANOPYRROLE-SULFONAMIDE PROGESTERONE RECEPTOR MODULATORS AND USES THEREOF | |
UY30805A1 (en) | NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS | |
UY30815A1 (en) | NON-STEROID MODULATORS OF THE PROGESTERONE RECEIVER | |
CL2008002027A1 (en) | Obeta-substituted 16alpha-fluoro-estra-1,3,5 (10) -triene derivative compounds: Pharmaceutical composition; and use of the compounds to treat diseases induced by estrogen deficiency, infertility, peri- and postmenopausal symptoms, rheumatic arthritis, inflammatory bowel diseases, among others. |